Literature DB >> 27630228

Magnitude and Quality of Cytokine and Chemokine Storm during Acute Infection Distinguish Nonprogressive and Progressive Simian Immunodeficiency Virus Infections of Nonhuman Primates.

Sheila M Keating1,2, John W Heitman3, Shiquan Wu3, Xutao Deng3, Andrea R Stacey4, Roland C Zahn5, Maurus de la Rosa5, Samantha L Finstad5, Jeffrey D Lifson6, Michael Piatak6, Marie-Claire Gauduin7, Benedikt M Kessler4,8, Nicola Ternette4,8, Angela Carville9, R Paul Johnson10, Ronald C Desrosiers11, Norman L Letvin5, Persephone Borrow4, Philip J Norris3,2,12, Joern E Schmitz5.   

Abstract

Acute human immunodeficiency virus (HIV) infection represents a period of intense immune perturbation and activation of the host immune system. Study of the eclipse and viral expansion phases of infection is difficult in humans, but studies in nonprogressive and progressive nonhuman primate (NHP) infection models can provide significant insight into critical events occurring during this time. Cytokines, chemokines, and other soluble immune factors were measured in longitudinal samples from rhesus macaques infected with either SIVmac251 (progressive infection) or SIVmac239Δnef (attenuated/nonprogressive infection) and from African green monkeys infected with SIVsab9315BR (nonpathogenic infection). Levels of acute-phase peak viral replication were highest in SIVmac251 infection but correlated positively with viremia at 3 months postinfection in all three infection models. SIVmac251 infection was associated with stronger corresponding acute-phase cytokine/chemokine responses than the nonprogressive infections. The production of interleukin 15 (IL-15), IL-18, gamma interferon (IFN-γ), granulocyte colony-stimulating factor (G-CSF), monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1β (MIP-1β), and serum amyloid A protein (SAA) during acute SIVmac251 infection, but not during SIVmac239Δnef or SIVsab9315BR infection, correlated positively with chronic viremia at 3 months postinfection. Acute-phase production of MCP-1 correlated with viremia at 3 months postinfection in both nonprogressive infections. Finally, a positive correlation between the acute-phase area under the curve (AUC) for IL-6 and soluble CD40 ligand (sCD40L) and chronic viremia was observed only for the nonprogressive infection models. While we observed dynamic acute inflammatory immune responses in both progressive and nonprogressive SIV infections, the responses in the nonprogressive infections were not only lower in magnitude but also qualitatively different biomarkers of disease progression. IMPORTANCE: NHP models of HIV infection constitute a powerful tool with which to study viral pathogenesis in order to gain critical information for a better understanding of HIV infection in humans. Here we studied progressive and nonprogressive simian immunodeficiency virus (SIV) infection models in both natural and nonnatural host NHP species. Regardless of the pathogenicity of the virus infection and regardless of the NHP species studied, the magnitude of viremia, as measured by area under the curve, during the first 4 weeks of infection correlated positively with viremia in chronic infection. The magnitude of cytokine and chemokine responses during primary infection also correlated positively with both acute-phase and chronic viremia. However, the pattern and levels of specific cytokines and chemokines produced differed between nonprogressive and progressive SIV infection models. The qualitative differences in the early immune response in pathogenic and nonpathogenic infections identified here may be important determinants of the subsequent disease course.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27630228      PMCID: PMC5105668          DOI: 10.1128/JVI.01061-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS.

Authors:  A Nichole Cline; Julian W Bess; Michael Piatak; Jeffrey D Lifson
Journal:  J Med Primatol       Date:  2005-10       Impact factor: 0.667

2.  Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease.

Authors:  S R Broussard; S I Staprans; R White; E M Whitehead; M B Feinberg; J S Allan
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease.

Authors:  Roland C Zahn; Melisa D Rett; Ming Li; Haili Tang; Birgit Korioth-Schmitz; Harikrishnan Balachandran; Robert White; Sarah Pryputniewicz; Norman L Letvin; Amitinder Kaur; David C Montefiori; Angela Carville; Vanessa M Hirsch; Jonathan S Allan; Jörn E Schmitz
Journal:  Blood       Date:  2010-02-10       Impact factor: 22.113

Review 4.  Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts.

Authors:  Donald L Sodora; Jonathan S Allan; Cristian Apetrei; Jason M Brenchley; Daniel C Douek; James G Else; Jacob D Estes; Beatrice H Hahn; Vanessa M Hirsch; Amitinder Kaur; Frank Kirchhoff; Michaela Muller-Trutwin; Ivona Pandrea; Jörn E Schmitz; Guido Silvestri
Journal:  Nat Med       Date:  2009-08       Impact factor: 53.440

5.  Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression.

Authors:  Lindi Roberts; Jo-Ann S Passmore; Carolyn Williamson; Francesca Little; Lisa M Bebell; Koleka Mlisana; Wendy A Burgers; Francois van Loggerenberg; Gerhard Walzl; Joel F Djoba Siawaya; Quarraisha Abdool Karim; Salim S Abdool Karim
Journal:  AIDS       Date:  2010-03-27       Impact factor: 4.177

6.  Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections.

Authors:  Andrea R Stacey; Philip J Norris; Li Qin; Elizabeth A Haygreen; Elizabeth Taylor; John Heitman; Mila Lebedeva; Allan DeCamp; Dongfeng Li; Douglas Grove; Steven G Self; Persephone Borrow
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

7.  Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial.

Authors:  Bethan McDonald; Sikhulile Moyo; Lesego Gabaitiri; Simani Gaseitsiwe; Hermann Bussmann; John R Koethe; Rosemary Musonda; Joseph Makhema; Vladimir Novitsky; Richard G Marlink; C William Wester; Max Essex
Journal:  AIDS Res Hum Retroviruses       Date:  2013-05-09       Impact factor: 2.205

8.  Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo.

Authors:  P Aukrust; S S Frøland; N B Liabakk; F Müller; I Nordøy; C Haug; T Espevik
Journal:  Blood       Date:  1994-10-01       Impact factor: 22.113

9.  Regulatory B cells are induced by gut microbiota-driven interleukin-1β and interleukin-6 production.

Authors:  Elizabeth C Rosser; Kristine Oleinika; Silvia Tonon; Ronan Doyle; Anneleen Bosma; Natalie A Carter; Kathryn A Harris; Simon A Jones; Nigel Klein; Claudia Mauri
Journal:  Nat Med       Date:  2014-10-19       Impact factor: 53.440

10.  Experimental colitis in SIV-uninfected rhesus macaques recapitulates important features of pathogenic SIV infection.

Authors:  Xing Pei Hao; Carissa M Lucero; Baris Turkbey; Marcelino L Bernardo; David R Morcock; Claire Deleage; Charles M Trubey; Jeremy Smedley; Nichole R Klatt; Luis D Giavedoni; Jan Kristoff; Amy Xu; Gregory Q Del Prete; Brandon F Keele; Srinivas S Rao; W Gregory Alvord; Peter L Choyke; Jeffrey D Lifson; Jason M Brenchley; Cristian Apetrei; Ivona Pandrea; Jacob D Estes
Journal:  Nat Commun       Date:  2015-08-18       Impact factor: 14.919

View more
  13 in total

1.  mTOR signaling mediates effects of common gamma-chain cytokines on T cell proliferation and exhaustion: implications for HIV-1 persistence and cure research.

Authors:  Harry E Taylor; Nina A Calantone; Richard T D'Aquila
Journal:  AIDS       Date:  2018-11-28       Impact factor: 4.177

2.  Early Antiretroviral Therapy Prevents Viral Infection of Monocytes and Inflammation in Simian Immunodeficiency Virus-Infected Rhesus Macaques.

Authors:  Henintsoa Rabezanahary; Julien Clain; Gina Racine; Guadalupe Andreani; Ghita Benmadid-Laktout; Chloé Borde; Fabrizio Mammano; Thibault Mesplèdes; Petronela Ancuta; Ouafa Zghidi-Abouzid; Jérôme Estaquier
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

3.  A global perspective on hepatitis B-related single nucleotide polymorphisms and evolution during human migration.

Authors:  Dar-In Tai; Wen-Juei Jeng; Chun-Yen Lin
Journal:  Hepatol Commun       Date:  2017-11-06

4.  A20 upregulation during treated HIV disease is associated with intestinal epithelial cell recovery and function.

Authors:  Avantika S Chitre; Michael G Kattah; Yenny Y Rosli; Montha Pao; Monika Deswal; Steven G Deeks; Peter W Hunt; Mohamed Abdel-Mohsen; Luis J Montaner; Charles C Kim; Averil Ma; Ma Somsouk; Joseph M McCune
Journal:  PLoS Pathog       Date:  2018-03-05       Impact factor: 6.823

Review 5.  Cytokine-Mediated Tissue Injury in Non-human Primate Models of Viral Infections.

Authors:  Cordelia Manickam; Spandan V Shah; Olivier Lucar; Daniel R Ram; R Keith Reeves
Journal:  Front Immunol       Date:  2018-12-04       Impact factor: 7.561

6.  Myeloid and CD4 T Cells Comprise the Latent Reservoir in Antiretroviral Therapy-Suppressed SIVmac251-Infected Macaques.

Authors:  Celina M Abreu; Rebecca T Veenhuis; Lucio Gama; Janice E Clements; Claudia R Avalos; Shelby Graham; Daymond R Parrilla; Edna A Ferreira; Suzanne E Queen; Erin N Shirk; Brandon T Bullock; Ming Li; Kelly A Metcalf Pate; Sarah E Beck; Lisa M Mangus; Joseph L Mankowski; Feilim Mac Gabhann; Shelby L O'Connor
Journal:  mBio       Date:  2019-08-20       Impact factor: 7.867

7.  MAIT cells are functionally impaired in a Mauritian cynomolgus macaque model of SIV and Mtb co-infection.

Authors:  Amy L Ellis; Alexis J Balgeman; Erica C Larson; Mark A Rodgers; Cassaundra Ameel; Tonilynn Baranowski; Nadean Kannal; Pauline Maiello; Jennifer A Juno; Charles A Scanga; Shelby L O'Connor
Journal:  PLoS Pathog       Date:  2020-05-20       Impact factor: 6.823

Review 8.  Evolution and Diversity of Immune Responses during Acute HIV Infection.

Authors:  Samuel W Kazer; Bruce D Walker; Alex K Shalek
Journal:  Immunity       Date:  2020-11-17       Impact factor: 31.745

9.  Association between the cytokine storm, immune cell dynamics, and viral replicative capacity in hyperacute HIV infection.

Authors:  Daniel M Muema; Ngomu A Akilimali; Okechukwu C Ndumnego; Sipho S Rasehlo; Raveshni Durgiah; Doty B A Ojwach; Nasreen Ismail; Mary Dong; Amber Moodley; Krista L Dong; Zaza M Ndhlovu; Jenniffer M Mabuka; Bruce D Walker; Jaclyn K Mann; Thumbi Ndung'u
Journal:  BMC Med       Date:  2020-03-25       Impact factor: 8.775

10.  The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progression.

Authors:  Xiaowan Yin; Zhuo Wang; Tong Wu; Meichen Ma; Zining Zhang; Zhenxing Chu; Qinghai Hu; Haibo Ding; Xiaoxu Han; Junjie Xu; Hong Shang; Yongjun Jiang
Journal:  J Transl Med       Date:  2019-12-13       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.